AmerisourceBergen stock soars to all-time high of $271.17

Published 26/03/2025, 14:52
AmerisourceBergen stock soars to all-time high of $271.17

AmerisourceBergen (NYSE:COR) Corporation (NYSE: ABC), a $52 billion market cap healthcare giant, has reached a new pinnacle as its stock price soared to an all-time high of $271.17, marking a significant milestone for the pharmaceutical sourcing and distribution services company. According to InvestingPro data, the company maintains a GOOD financial health score. This peak comes amidst a robust year for AmerisourceBergen, which has delivered even stronger recent performance with a 20.46% gain over the past six months and a 19.76% rise year-to-date. Investors and industry analysts alike are closely monitoring the company’s performance, as it continues to navigate the dynamic healthcare landscape and capitalize on growth opportunities. The all-time high represents not only a triumph for AmerisourceBergen but also signals confidence from the market in the company’s strategic direction and its potential for sustained growth. InvestingPro analysis suggests the stock remains slightly undervalued, with additional insights available in the comprehensive Pro Research Report.

In other recent news, Cencora, Inc. has adjusted its fiscal year 2025 earnings per share (EPS) guidance following the acquisition of Retina Consultants of America. The transaction, valued at $4.4 billion, resulted in an upward revision of Cencora’s adjusted EPS to a range of $15.15 to $15.45, from the previous estimate of $14.80 to $15.10. This acquisition is expected to enhance Cencora’s position in specialty medical services and expand its management services organization solutions. Additionally, Leerink Partners has increased Cencora’s stock price target to $301, maintaining an Outperform rating, influenced by the company’s strong performance in its pharmaceutical distribution segment. The updated guidance for U.S. Healthcare EBIT showed a nearly 4% rise, further supporting Leerink’s positive outlook. In corporate governance news, Cencora announced the retirement of board members Richard W. Gochnauer and Kathleen W. Hyle, effective at the next Annual Meeting of Stockholders. Meanwhile, shareholders recently approved the executive compensation package and elected directors during the company’s Annual Meeting. The ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year 2025 was also confirmed.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.